(2)
DALLAS, TX / ACCESSWIRE / February 16, 2021 / According to new report added in Report Banana offerings, there are significant money making opportunities available in the bioinformatics market. Companies planning to enter this market need to prepare and differentiate to maximize their return on investment.
In terms of opportunities, the bioinformatics market is expected to grow from $7.73 billion in 2018 to USD 13.50 billion in 2023; it is expected to grow at a CAGR of 14.5% during the forecast period. Market for the metabolomics application segment is expected to grow at the highest CAGR and by sector, medical biotechnology segment is expected to grow at the highest rate during the forecast period.
The Bioinformatics Market is Expected to Reach $13 50 Billion in 2023 with CAGR of 14 5%
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Global Next-Generation Sequencing Market 2021 Industry Key Players, Share, Trend, Segmentation and Forecast to 2027
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Healthcare experts at BIS have found genomic data analysis and interpretation industry to be one of the most rapidly evolving and dynamic markets and the global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030.
The market is driven by certain factors, which include decreasing cost of sequencing, global increase in cancer prevalence, and increasing number of population genomics initiative, among others, are fueling the growth of the global genomic data analysis and interpretation market.
The market is favored by the developments in the field of genomics and bioinformatics. Currently, the genomic data analysis and interpretation industry is witnessing an upsurge due to the growing number of genomic research initiatives being undertaken by the developing and developed countries coupled with the decreasing cost of sequencing, res